These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 33314803

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Predicting the Prognosis of Gastric Cancer by Albumin/Globulin Ratio and the Prognostic Nutritional Index.
    Zhang Y, Zhu JY, Zhou LN, Tang M, Chen MB, Tao M.
    Nutr Cancer; 2020; 72(4):635-644. PubMed ID: 31423840
    [Abstract] [Full Text] [Related]

  • 43. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS, Tan J, Zhou XL, Song YQ, Song YJ.
    J Transl Med; 2017 Oct 31; 15(1):221. PubMed ID: 29089030
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer.
    Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, Komaki T, Kagawa K, Yasuda H, Naito Y, Itoh Y.
    Sci Rep; 2020 Oct 30; 10(1):18758. PubMed ID: 33127996
    [Abstract] [Full Text] [Related]

  • 46. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.
    Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H, Ohbayashi C, Kichikawa K, Ikeda N.
    Pancreatology; 2019 Jul 30; 19(5):722-728. PubMed ID: 31153778
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
    Wang C, He W, Yuan Y, Zhang Y, Li K, Zou R, Liao Y, Liu W, Yang Z, Zuo D, Qiu J, Zheng Y, Li B, Yuan Y.
    Liver Int; 2020 Jan 30; 40(1):229-239. PubMed ID: 31652394
    [Abstract] [Full Text] [Related]

  • 54. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma.
    Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N, Koike K, Nishino H, Tajiri H.
    Br J Cancer; 2012 Sep 04; 107(6):988-93. PubMed ID: 22878374
    [Abstract] [Full Text] [Related]

  • 55. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
    Fizazi K, Delva R, Caty A, Chevreau C, Kerbrat P, Rolland F, Priou F, Geoffrois L, Rixe O, Beuzeboc P, Malhaire JP, Culine S, Aubelle MS, Laplanche A.
    Eur Urol; 2014 Feb 04; 65(2):381-6. PubMed ID: 24094847
    [Abstract] [Full Text] [Related]

  • 56. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.
    de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, Cook P, de Prijck L, Stenning S, Collette L.
    J Clin Oncol; 2001 Mar 15; 19(6):1629-40. PubMed ID: 11250991
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.